M. Blute

89Zr-girentuximab PET/CT Enables Noninvasive Assessment of Indeterminate Renal Masses and Metastatic Clear-Cell Renal Cell Carcinoma.
20260 citationsauthor #5
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance.
20252 citationsauthor #10
A contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinoma
20244 citationsauthor #8
Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus.
202334 citationsauthor #3
The Progession Landscape of Diagnostic and Treatment Options for Kidney Cancer.
20231 citationsauthor #2
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer.
20235 citationsauthor #12
Renal Cancer: Old and New Paradigms
20230 citationsauthor #2
Clinicopathological and oncological significance of persistent prostate-specific antigen after radical prostatectomy: A systematic review and meta-analysis
20227 citationsauthor #5
The Clinical Significance of the Positive Surgical Margin and Dominant Tumor Laterality Following Radical Prostatectomy: A Retrospective Study
20220 citationsauthor #10
The impact of a positive family history on clinical and pathologic outcomes of active surveillance for prostate cancer.
20211 citationsauthor #8
Prognostic and predictive biomarkers for metastatic renal cell carcinoma
20213 citationsauthor #4
Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification.
202115 citationsauthor #10
Treatment trends of muscle invasive bladder cancer: Evidence from the Surveillance, Epidemiology, and End Results database, 1988 to 2013
20217 citationsauthor #2
PD17-05 THE IMPACT OF A POSITIVE FAMILY HISTORY OF HEREDITARY CANCER-ASSOCIATED MALIGNANCIES ON OUTCOMES OF ACTIVE SURVEILLANCE FOR PROSTATE CANCER
20210 citationsauthor #7
Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy
202122 citationsauthor #7
Conditional progression-free survival in men on active surveillance for prostate cancer stratified by NCCN risk.
20210 citationsauthor #7
Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence.
202019 citationsauthor #7
Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy
20202 citationsauthor #4
Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level
202014 citationsauthor #17
Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing
202027 citationsauthor #19
Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis
202015 citationsauthor #5
Trends of Muscle Invasive Bladder Cancer: Evidence from the SEER Database, 1988 to 2013
20200 citationsauthor #2
Long-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomy
20201 citationsauthor #10
MP48-19 NEED FOR INTERVENTION AND SURVIVAL IN A COHORT OF PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
20190 citationsauthor #9
TESTICULAR CANCER
20191 citationsauthor #2
Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis
201925 citationsauthor #10
MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER.
201916 citationsauthor #9
Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years
201920 citationsauthor #7
Concordance of systematic and fusion biopsy with surgical pathology.
20191 citationsauthor #10
Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies
201856 citationsauthor #6
Using aorta lesion attenuation difference (ALAD) on preoperative contrast-enhanced CT scan to differentiate between malignant and benign renal tumors.
20181 citationsauthor #7
Evaluation of the timing of adjuvant mitomycin C following nephroureterectomy for urothelial carcinoma of the upper urinary tract.
20181 citationsauthor #5
MP17-14 THE PROGNOSTIC IMPACT OF A NEGATIVE CONFIRMATORY BIOPSY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
20180 citationsauthor #7
The prognostic impact of a negative confirmatory biopsy in men on active surveillance for prostate cancer.
20180 citationsauthor #7
COMPARING COMPLICATIONS AND SURVIVAL OF PRIMARY CYSTECTOMY VS. SALAVAGE CYSTECTOMY AFTER TRIMODAL THERAPY: PD36‐12
20170 citationsauthor #6
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.
201781 citationsauthor #10
Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy
201733 citationsauthor #1
A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancer
201710 citationsauthor #1
Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression
201711 citationsauthor #1
Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus
201730 citationsauthor #11
SAFETY AND EFFICACY OF POST‐OPERATIVE EXTENDED‐DURATION VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HIGH‐RISK UROLOGIC ONCOLOGY PATIENTS: MP92‐01
20170 citationsauthor #3
Lymph Node Dissection for Small Renal Masses.
20170 citationsauthor #1
Case 5-2017. A 19-Year-Old Man with Hematuria and a Retroperitoneal Mass.
201710 citationsauthor #1
ACTIVE SURVEILLANCE FOR LOW‐RISK PROSTATE CANCER IN MEN UNDER 60 YEARS OF AGE: PD55‐03
20170 citationsauthor #6
Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric Analysis.
20177 citationsauthor #1
Delayed Intervention of Small Renal Masses on Active Surveillance
201717 citationsauthor #2
COMPARING PREDICTIVE ACCURACY FOR FOUR PROGNOSTIC MODELS OF RECURRENCE FOLLOWING SURGERY IN NON‐METASTATIC RENAL CELL CARCINOMA WITH THROMBUS USING CONTEMPORARY DATA FROM SIX INSTITUTIONS: MP55‐13
20170 citationsauthor #8
ACTIVE SURVEILLANCE IS A VIABLE OPTION FOR MEN WITH BORDERLINE LOW‐RISK PROSTATE CANCER: PD55‐05
20170 citationsauthor #9
Loss of Igf2 Gene Imprinting in Murine Prostate Promotes Widespread Neoplastic Growth.
201728 citationsauthor #6
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
20161,130 citationsauthor #189
PD41-02 NOMOGRAM TO PREDICT RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS USING A MULTI-CENTER CONTEMPORARY SERIES
20160 citationsauthor #1
MP13-12 MODERATE CHRONIC KIDNEY DISEASE (EGFR <60 ML/MIN) PREDICTS RECURRENCE AND PROGRESSION IN BLADDER CANCER PATIENTS TREATED WITH TRANSURETHRAL RESECTION
20160 citationsauthor #1
Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer
20160 citationsauthor #9
The evolving role of renal mass biopsy.
20162 citationsauthor #1
MP49-17 CLINICAL OUTCOMES OF PATIENTS WITH HISTOLOGIC VARIANTS OF BLADDER CANCER TREATED WITH TRIMODAL BLADDER-SPARING THERAPY
20160 citationsauthor #9
A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery.
20163 citationsauthor #2
Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer
20166 citationsauthor #1
Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals.
201627 citationsauthor #11
MP64-15 A CRITICAL ANALYSIS OF POSTOPERATIVE MORBIDITY IN MORBIDLY OBESE PATIENTS FOLLOWING RENAL CANCER SURGERY
20160 citationsauthor #2
The impact of histological variants on bladder cancer survival: A population-based analysis.
20161 citationsauthor #5
MP50-05 SYNTHETIC LETHAL METABOLIC TARGETING OF CELLULAR SENESCENCE IN PROSTATE CANCER WITH THE REPURPOSED DRUG METFORMIN
20163 citationsauthor #2
Management of the Incidental Adrenal Mass.
201616 citationsauthor #2
Morbid obesity is not associated with worse outcomes following surgery for renal cell cancer (RCC)
20150 citationsauthor #2
MP59-04 OPTIMAL TREATMENT FOR 4-10CM RENAL CELL CARCINOMA: A SURVEY OF ENDOUROLOGISTS AND UROLOGIC ONCOLOGISTS
20150 citationsauthor #2
MP55-11 SYNTHETIC LETHAL METABOLIC TARGETING OF CELLULAR SENESCENCE IN PROSTATE CANCER WITH METFORMIN
20152 citationsauthor #1
MP37-20 NEOADJUVANT ANDROGEN DEPRIVATION THERAPY INDUCES SENESCENCE IN RADICAL PROSTATECTOMY SPECIMENS
20150 citationsauthor #1
Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years.
201533 citationsauthor #11
MP50-07 THE ASSOCIATION BETWEEN OBESITY AND INCIDENCE OF TOTAL AND FATAL RENAL CELL CARCINOMA IN TWO PROSPECTIVE COHORTS
20150 citationsauthor #9
Addressing the need for repeat prostate biopsy: new technology and approaches
201529 citationsauthor #1
Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings.
201590 citationsauthor #5
MP50-09 ROLE OF REPEAT BIOPSY IN THE FOLLOW-UP OF RENAL LESIONS WITH A PRIOR NON-DIAGNOSTIC BIOPSY OF THE SAME MASS
20150 citationsauthor #6
Abstract A45: The association between type 2 diabetes mellitus and incidence of renal cell carcinoma (RCC) and fatal RCC in two prospective cohorts
20150 citationsauthor #8
MP26-08 RENIN-ANGIOTENSIN INHIBITORS DECREASE RECURRENCE AFTER TURBT IN NON-MUSCLE INVASIVE BLADDER CANCER
20150 citationsauthor #1
The association between obesity and incidence of total and fatal renal cell carcinoma in two prospective cohorts.
20150 citationsauthor #9
Percutaneous biopsy for risk stratification of renal masses
201532 citationsauthor #1
MP83-11 LONG-TERM PATIENT-REPORTED FUNCTIONAL OUTCOMES FOLLOWING OPEN, LAPAROSCOPIC, AND ROBOTIC-ASSISTED RADICAL PROSTATECTOMY PERFORMED BY HIGH VOLUME SURGEONS
20150 citationsauthor #10
The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications
201525 citationsauthor #1
PD35-05 MULTICENTER VALIDATION OF PREDICTIVE MODEL FOR POSTSURGICAL RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS
20150 citationsauthor #1
Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
201512 citationsauthor #8
Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
201517 citationsauthor #1
MP35-09 MANAGEMENT OF SUSPICIOUS LIPID POOR RENAL MASSES IN THE TUBEROUS SCLEROSIS COMPLEX PATIENT WITH MULTIPLE RENAL LESIONS
20150 citationsauthor #3
MP50-08 DIAGNOSTIC SUCCESS AND PREDICTION OF TUMOR SUBTYPE OF RENAL MASS BIOPSY IMPROVES WITH EXPERIENCE: LONGITUDINAL RESULTS IN A SINGLE SERIES COHORT OF 1233 TUMORS
20150 citationsauthor #9
MP44-16 PREDICTORS OF NON-DIAGNOSTIC RENAL MASS BIOPSY
20153 citationsauthor #1
MP26-09 MODERATE CHRONIC KIDNEY DISEASE (EGFR < 60 ML/MIN) PREDICTS RECURRENCE AND PROGRESSION IN BLADDER CANCER PATIENTS TREATED WITH TRANSURETHRAL RESECTION
20150 citationsauthor #1
Clinical significance of renin-angiotensin system inhibition on non-muscle invasive bladder cancer
20150 citationsauthor #2
The role of lymphadenectomy in the management of renal cell carcinoma
20147 citationsauthor #3
Caveat emptor.
20140 citationsauthor #3
Positive surgical margins after radical prostatectomy: does it matter?
201411 citationsauthor #2
Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer
201430 citationsauthor #3
Both Fleischner Society and the American College of Chest Physicians guidelines for the management of incidentally
20140 citationsauthor #6
EVALUATION OF PARTIAL VERSUS RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS 4-7CM
20140 citationsauthor #7
Potential role for androgen-deprivation therapy and pelvic radiation therapy in node-positive postprostatectomy prostate cancer.
20141 citationsauthor #2
Defining a standard set of patient-centered outcomes for men with localized prostate cancer.
2014229 citationsauthor #7
Prognostic significance of indeterminate lung nodules in renal cell carcinoma.
20148 citationsauthor #6
Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base.
201475 citationsauthor #10
674 CLINICOPATHOLOGIC CORRELATION AND BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOR INTERMEDIATE RISK PROSTATE CANCER: IMPLICATIONS FOR ACTIVE SURVEILLANCE
20130 citationsauthor #5
1065 TO BIOPSY OR NOT TO BIOPSY: RESULTS OF 1000 RENAL MASS BIOPSIES AT A SINGLE INSTITUTION
20133 citationsauthor #9
Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy.
20139 citationsauthor #2
Can radiotherapy be a viable salvage treatment option for the relapsed seminoma confined to the infra-diaphragm region recurring after primary chemotherapy for bulky stage II seminoma?
20135 citationsauthor #4
630 LIPID-POOR LESIONS OF TUBEROUS SCLEROSIS; A ROLE FOR PERCUTANEOUS BIOPSY
20130 citationsauthor #4

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT